LGALS3 and chronic kidney disease: Similarly, in children with end-stage renal disease undergoing regular hemodialysis, galectin-3 was identified as an early marker of diastolic dysfunction, underscoring its potential role in the early detection and monitoring of cardiac involvement in pediatric CKD [13].